René Heitner - Concepedia

Author

René Heitner

Also Known As

R Heitner, R. Heitner, Rene Heitner, René Heitner

Publications

708

Citations

H-Index

Concepts

All Affiliations

René Heitner is an author at University of the Witwatersrand specializing in medicine, pharmacotherapy, and substrate reduction therapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	119
2	Pathology	1	1	11
3	Genetic Epidemiology	1	1	11
4	Genetics	1	1	11
5	Hypertension	1	1	41

René Heitner

Publications

375

Citations

H-Index

Page 1

	Year	Citations
Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease Ari Zimran, Einat Brill‐Almon, Raul Chertkoff, Blood	2011	202
Low-Dose N-Butyldeoxynojirimycin (OGT 918) for Type I Gaucher Disease René Heitner, Deborah Elstein, Johannes M. F. G. Aerts, Blood Cells Molecules and Diseases Ogt 918Substrate Reduction TherapyPharmacotherapyAntimicrobial ChemotherapyMedicine	2002	97
Hypertension as the major problem of idiopathic arterial calcification of infancy Laurence S. Milner, René Heitner, Peter D. Thomson, The Journal of Pediatrics HypertensionVascular MalformationPediatricsCongenital Heart DefectMajor Problem	1984	41
Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study. René Heitner, Silke Arndt, Jonathan Levin PubMed	2004	13
Glucocerebrosidase gene mutations in black South Africans with Gaucher disease Silke Arndt, René Heitner, A.B. Lane, Blood Cells Molecules and Diseases GeneticsInherited Metabolic DiseaseGenetic EpidemiologyBlack South AfricansPathology	2009	11
Low-Dose N-Butyldeoxynojirimycin (OGT 918) for Type I Gaucher Disease René Heitner, Deborah Elstein, Johannes M. F. G. Aerts, Blood Cells Molecules and Diseases Ogt 918Substrate Reduction TherapyPharmacotherapyAntimicrobial ChemotherapyMedicine	2002	11

Page 1